216 related articles for article (PubMed ID: 15340000)
21. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
22. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
23. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
[TBL] [Abstract][Full Text] [Related]
24. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
[TBL] [Abstract][Full Text] [Related]
25. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
[TBL] [Abstract][Full Text] [Related]
26. Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients.
Sezer S; Uyar M; Akcay A; Arat Z; Kulah E; Ozdemir FN; Haberal M
Transplant Proc; 2005 Mar; 37(2):776-8. PubMed ID: 15848528
[TBL] [Abstract][Full Text] [Related]
27. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
Falaknazi K; Bagheri N; Taziki O
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes after failed renal transplantation-does dialysis modality matter?
Perl J; Bargman JM; Davies SJ; Jassal SV
Semin Dial; 2008; 21(3):239-44. PubMed ID: 18533967
[TBL] [Abstract][Full Text] [Related]
29. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
30. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
31. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
[TBL] [Abstract][Full Text] [Related]
32. The management of the failed renal allograft: an enigma with potential consequences.
Langone AJ; Chuang P
Semin Dial; 2005; 18(3):185-7. PubMed ID: 15934959
[TBL] [Abstract][Full Text] [Related]
33. Timing of return to dialysis in patients with failing kidney transplants.
Molnar MZ; Ichii H; Lineen J; Foster CE; Mathe Z; Schiff J; Kim SJ; Pahl MV; Amin AN; Kalantar-Zadeh K; Kovesdy CP
Semin Dial; 2013; 26(6):667-74. PubMed ID: 24016076
[TBL] [Abstract][Full Text] [Related]
34. Patient outcomes after kidney allograft loss.
Marcén R; Teruel JL
Transplant Rev (Orlando); 2008 Jan; 22(1):62-72. PubMed ID: 18631859
[TBL] [Abstract][Full Text] [Related]
35. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
[TBL] [Abstract][Full Text] [Related]
36. Comparison of peritoneal dialysis and hemodialysis after kidney transplant failure.
Kang GW; Jang MH; Hwang EA; Park SB; Han SY
Transplant Proc; 2013 Oct; 45(8):2946-8. PubMed ID: 24157009
[TBL] [Abstract][Full Text] [Related]
37. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
38. [Can the treatment with L-carnitine improve the inflammation in chronic hemodialysis patients?].
Grazi G; Meriggioli M; Donati G
G Ital Nefrol; 2004; 21 Suppl 30():S204-7. PubMed ID: 15750986
[TBL] [Abstract][Full Text] [Related]
39. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
[TBL] [Abstract][Full Text] [Related]
40. The failed renal transplant: in or out?
Bennett WM
Semin Dial; 2005; 18(3):188-9. PubMed ID: 15934960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
